MAGNI, PAOLO
MAGNI, PAOLO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Advancing atherosclerosis research: The Power of lipid imaging with MALDI-MSI
2025 C.H.M. Bookmeyer, F.X. Correig, L. Masana, P. Magni, Ó. Yanes, M. Vinaixa
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
2025 H. Berisha, R. Hattab, L. Comi, C. Giglione, S. Migliaccio, P. Magni
Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies
2025 D. Kardassis, C. Vindis, C.S. Stancu, L. Toma, A.V. Gafencu, A. Georgescu, N. Alexandru-Moise, F. Molica, B.R. Kwak, A. Burlacu, I.F. Hall, E. Butoi, P. Magni, J. Wu, S. Novella, L.F. Gamon, M.J. Davies, A. Caporali, F. de la Cuesta, T. Mitić
Web discussions on cardiovascular diseases: pre-COVID-19 evaluation and impact of the COVID-19 pandemic – Web listening analysis in the Italian population
2024 I. Cecchini, M. Biroli, K. Massaroni, E. Folco, M.R. Montebelli, G. Ciancamerla, D. Giudice, R.F.E. Pedretti, P. Magni
Isolation and confinement in space and underwater missions
2024 M. Monici, F. Cialdai, C. Risaliti, M. Lulli, A. Amedei, D. Cavalieri, M. Marvasi, S. Bohm, A. Osterman, A. Choukér, J. Irina Buchheim, L. Morbidelli, C. Iorio, A.M. Rizzo, P. Magni, F. Strollo, A. Sundaresan, V. Mann, A. Papa, S. Oliva, A. Alcibiade, D. Antonacci, I. Antunes, J. Gabriel Rios, F. Ferranti
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
2024 L. Comi, C. Giglione, F.T. Klinaku, F. Pialorsi, V. Tollemeto, M. Zurlo, A. Seneci, P. Magni
Insulin-like Growth Factor 1, Growth Hormone, and Anti-Müllerian Hormone Receptors Are Differentially Expressed during GnRH Neuron Development
2023 A.J.J. Paganoni, R. Cannarella, R. Oleari, F. Amoruso, R. Antal, M. Ruzza, C. Olivieri, R. Angela Condorelli, S. La Vignera, F. Tolaj, A. Cariboni, A.E. Calogero, P. Magni
Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study
2023 E. Mattavelli, E. Olmastroni, M. Casula, L. Grigore, F. Pellegatta, A. Baragetti, P. Magni, A.L. Catapano
Transcriptomic research in atherosclerosis: Unravelling plaque phenotype and overcoming methodological challenges
2023 M. Sopić, K. Karaduzovic-Hadziabdic, D. Kardassis, L. Maegdefessel, F. Martelli, A. Meerson, J. Munjas, L.S. Niculescu, M. Stoll, P. Magni, Y. Devaux
Multiomics tools for improved atherosclerotic cardiovascular disease management
2023 M. Sopic, B. Vilne, E. Gerdts, F. Trindade, S. Uchida, S. Khatib, S.B. Wettinger, Y. Devaux, P. Magni
The sex-associated burden of atherosclerotic cardiovascular diseases: An update on prevention strategies
2023 P. Magni
Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research
2023 M. Sopic, G. Kararigas, Y. Devaux, P. Magni
Anti-Inflammatory, Antioxidant Activities, and Phytochemical Characterization of Edible Plants Exerting Synergistic Effects in Human Gastric Epithelial Cells
2023 A.P.N. Atchan, O.C. Monthe, A.D. Tchamgoue, Y. Singh, S.T. Shivashankara, M.K. Selvi, G.A. Agbor, P. Magni, S. Piazza, U.V. Manjappara, J. Kuiate, M. Dell'Agli
Risk Factors and Immunoinflammatory Mechanisms Leading to Atherosclerosis: Focus on the Role of Oral Microbiota Dysbiosis
2023 R. Mattia Ricciardi, A. Cipollone, D. D’Ardes, D. Di Giacomo, P. Pignatelli, F. Cipollone, M. Cristina Curia, P. Magni, M. Bucci
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps
2022 L. Comi, C. Giglione, F. Tolaj, C. Parolini, C. Olivieri, M. Ruzza, V. Tollemeto, M. Zurlo, F. Pialorsi, A. Seneci, P. Magni
Molecular and Functional Characterization of Human SW 872 Adipocytes as a Model System for Testing Nutraceutical Products
2022 C. Olivieri, M. Ruzza, F. Tolaj, L. Dadalt, P. Magni
Osteocalcin-expressing endothelial progenitor cells and serum osteocalcin forms are independent biomarkers of coronary atherosclerotic disease severity in male and female patients
2022 H.E. Shahrour, S. Al Fahom, G. Al-Massarani, A.R. Alsaadi, P. Magni
Nutraceuticals for dyslipidaemia and glucometabolic diseases : what the guidelines tell us (and do not tell, yet)
2022 M. Casula, A.L. Catapano, P. Magni
Special Issue: Nutraceutical Approaches to Cardiovascular and Metabolic Diseases: Evidence and Opportunities
2022 P. Magni, A. Baragetti, A. Poli
Ipertrigliceridemia: fisiopatologia e significato clinico
2022 C. Olivieri, D. Pisati, F. Sironi, T. Roversi, P. Magni